| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |